Thanks to the change in the Health and Human Services Department, ‘big pharma’ stocks are one of the very few sectors in equity-land that are seemingly unhappy about the forthcoming administration.
More By This Author:The Nvidia Business Model
Boeing Down 70%
Normalization Blues
Related Posts
Bombs Away
Fitch Warns Of “Historic Junk Milestone” As U.S Defaults Surge- Bitcoin price is correcting, but what does futures data show?
- Binary Options Trading Opportunities – November 16, 2015
- U.S. Bond Market Week In Review: Diverging Oil Price Predictions And Rising Junk Yields
Dollar Consolidates Weekly Gain, While Equities Ease To Start New Month
Leave A Comment